NovaBay Pharmaceuticals Inc. (NBY)
Symbol Info
Listed Symbol NBY
Name NovaBay Pharmaceuticals Inc.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $12,474,000
Latest Fiscal EPS $-0.46
Price Info
21 Day Moving Average $0.6244
21 Day EMA $0.620540
50 Day Moving Average $0.6229
50 Day EMA $0.701390
200 Day EMA $1.097710
200 Day Moving Average 1.081540
52 Week High $4.04
52 Week Low $0.23
52 Week Change $-60.322600
Alpha -0.026316
Beta 4.9796
Standard Deviation 0.484678
R2 0.124487
Periods 60
Share Information
10 Day Average Volume 204,812
20 Day Average Volume 529,511
30 Day Average Volume 1,141,199
50 Day Average Volume 1,037,278
Outstanding Shares 25,201,850
Float Shares 23,301,709
Percent Float 92.46%
Short Interest 663,019
Short Percent Float 2.60%
Short Interest Ratio 0.33
Short Date 2019-09-30
Holders
Institutions 31
Institute Holdings Date 2019-09-30
Institute Bought Previous 3 Months 395,389
Institute Holdings Percent 3.200000
Institute Sold Previous 3 Months 112,214
Insider Holdings Date 2019-08-31
Insider Bought Previous 3 Months 1
Insider Holdings Percent 7.50%
Insider Sold Previous 3 Months 5
Insiders Shares Owned 1,900,141
Price Change
7 Day Price Change $-0.0025
7 Day Percent Change -0.40%
21 Day Price Change $-0.0374
21 Day Percent Change -5.73%
30 Day Price Change $-0.0729
30 Day Percent Change -10.60%
Month To Date Price Change $0.0046
Month To Date Percent 0.75%
90 Day Price Change $-0.4665
90 Day Percent Change -43.13%
Quarter To Date $0.004600
Quarter To Date Percent 0.75%
180 Day Price Change $-0.485
180 Day Percent Change -44.09%
200 Day Price Change $-0.535
200 Day Percent Change -46.52%
Year To Date $-0.1577
Year To Date Percent -20.41%
Profile
Description NovaBay Pharmaceuticals Inc is a biopharmaceutical company. The company develops, manufactures, and markets anti-infective products for a multitude of uses. It is predominantly focused on commercializing prescription Avenova for the domestic eyecare market in the United States. Avenova is the only eye care product formulated with proprietary, stable and pure form of hypochlorous acid (marketed as Neutrox). NovaBay develops additional products containing Neutrox, including its NeutroPhase Skin and Wound Cleanser for wound care and CelleRx for the dermatology market. It has partnerships for NeutroPhase in the United States, as well as in other markets.
Details
Issue Type CS
Market Cap $15,499,138
Sec Type EQS
Auditor OUM & Co. LLP
Total Shares Outstanding 25,201,850
CEO Justin M. Hall
Employees 33
Last Audit UE
Classification
CIK 0001389545
Industry Biotechnology
Sector Healthcare
NAICS Pharmaceutical Preparation Manufacturing(325412)
Info
Address 2000 Powell Street
Suite 1150
Emeryville, CA 94608
Website https://www.novabay.com
Facisimile +1 510 474-1577
Telephone +1 510 899-8800
Email
Key Ratios
Profitability
EBIT Margin -88.3
EBITDA Margin -86.6
Pre-Tax Profit Margin -415.6
Profit Margin Cont -
Gross Margin 84.90
Profit Margin TOT -
Income Statements
Revenue $6,843,000
Revenue Per Share $0.2715
Revenue 3 Years $-3.6
Revenue 5 Years $69.23
Valuation Measures
PE Ratio -
Enterprise Value $16,433,209
Price To Sales 2.264962
Price To Free Cash -2.1
PE High Last 5 Years -
Price To Book 8.9
Price To Cash Flow 24.7
PE Low Last 5 Years -
Price To Tangible Book 8.9
Financial Strength
Total Debt To Equity 2.8
Int Coverage -
Current Ratio 2.2
Leverage Ratio 11.0
Quick Ratio 1.6
Long Term Debt To Capital 0.69
Assets
Receivables Turnover 1.1
Invoice Turnover 2.90
Assets Turnover 0.20
Management Effectiveness
Return Assets -88.3
Return On Equity -209.39
Return On Capital -102.78
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
AMEX
NBY
NovaBay Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.